Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana M Brainard

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|December 28, 2019
Gender Parity in Clinical PrEP TrialsDiana M Brainard, Scott McCallister
The New England Journal of Medicine|November 5, 2015
Bradyarrhythmias Associated with Sofosbuvir TreatmentDiana M Brainard, John G McHutchison
The New England Journal of Medicine|February 7, 2003
Images in clinical medicine. Thoracic echinococcosisDiana M Brainard, Edward T Ryan
Journal of Hepatology|August 10, 2017
Reply to: "Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries"Stefan Zeuzem, Hadas Dvory-Sobol, Diana M Brainard
Journal of Hepatology|November 17, 2018
Sofosbuvir/velpatasvir for patients with chronic genotype 3 HCV infection with compensated cirrhosis: Response to EASL Recommendations on Treatment of Hepatitis C 2018Luisa M Stamm, Diana M Brainard, John G McHutchison
Clinical Pharmacokinetics|April 13, 2018
Drug-Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/SofosbuvirPolina German, Anita Mathias, Diana M Brainard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
Reply to Ozaras et alMark S Sulkowski, Diana M Brainard, Jenny C Yang, et al.
Journal of Clinical Pharmacology|January 7, 2011
Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitorDiana M Brainard, Larissa A Wenning, Julie A Stone, et al.
Clinical Pharmacology in Drug Development|October 24, 2017
A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy SubjectsPolina German, Anita Mathias, Diana M Brainard, et al.
Hepatology Communications|December 18, 2018
Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver TransplantationMaria G Cardona-Gonzalez, Jason D Goldman, Lawrence Narayan, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|December 28, 2019
Gender Parity in Clinical PrEP TrialsDiana M Brainard, Scott McCallister
The New England Journal of Medicine|November 5, 2015
Bradyarrhythmias Associated with Sofosbuvir TreatmentDiana M Brainard, John G McHutchison
The New England Journal of Medicine|February 7, 2003
Images in clinical medicine. Thoracic echinococcosisDiana M Brainard, Edward T Ryan
Journal of Hepatology|August 10, 2017
Reply to: "Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries"Stefan Zeuzem, Hadas Dvory-Sobol, Diana M Brainard
Journal of Hepatology|November 17, 2018
Sofosbuvir/velpatasvir for patients with chronic genotype 3 HCV infection with compensated cirrhosis: Response to EASL Recommendations on Treatment of Hepatitis C 2018Luisa M Stamm, Diana M Brainard, John G McHutchison
Clinical Pharmacokinetics|April 13, 2018
Drug-Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/SofosbuvirPolina German, Anita Mathias, Diana M Brainard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
Reply to Ozaras et alMark S Sulkowski, Diana M Brainard, Jenny C Yang, et al.
Journal of Clinical Pharmacology|January 7, 2011
Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitorDiana M Brainard, Larissa A Wenning, Julie A Stone, et al.
Clinical Pharmacology in Drug Development|October 24, 2017
A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy SubjectsPolina German, Anita Mathias, Diana M Brainard, et al.
Hepatology Communications|December 18, 2018
Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver TransplantationMaria G Cardona-Gonzalez, Jason D Goldman, Lawrence Narayan, et al.
Pageof 13